All funds from this campaign support the most pressing clinical trial at the time. We are committed to funding cutting-edge research to improve treatments for children with cancer. We specifically focus on funding research for neuroblastoma, which is a childhood cancer that most commonly affects kids under 5 years old. It tends to go undetected until the tumor metastasizes and then symptoms present. Neuroblastoma is super aggressive and the prognosis is poor with less than a 60% survival rate with standard chemotherapy. There is a 50% chance of relapse and there is no known treatment or cure for relapsed neuroblastoma. New, more effective treatments for neuroblastoma is our top priority.